(b)(4).On an unreported date ¿in late (b)(6)¿ the patient developed peritonitis.The cause of this peritonitis was use error reported to be due to a break in aseptic technique by the patient.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A formal review of the label for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.
|
It was reported that a patient experienced a breach in aseptic technique which resulted in peritonitis coincident with peritoneal dialysis (pd) therapy.The breach in aseptic technique was further described as the patient made a mistake of touch contamination.On an unreported date, the patient went to the emergency room for the event, however, was not hospitalized.On an unknown date, the patient began treatment for the peritonitis with vancomycin, intraperitoneally, (dose and frequency not reported).At the time of this report, treatment with vancomycin was ongoing, the peritonitis was resolving, the patient was recovering from the event, and dianeal/extraneal therapies were ongoing.No additional information is available.
|